StockData
Zivo Bioscience, Inc. logo

Zivo Bioscience, Inc. (ZIVO) stock

ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2025, quý kết thúc ngày Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 1/30
$6.80+0.30 (+4.62%)

Close on Oct 19, 2026Market cap $25.96MP/E –Yield –

Zivo Bioscience enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Zivo Bioscience's enterprise value was $26.01M on Oct 19, 2026, against $53.43M a year earlier. Over the last 5 years it ranged from -$260.91K to $214.95M, with a median of $60.50M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$26.01M-21.9%
2025Dec 31, 2025$33.30M-55.5%
2024Dec 31, 2024$74.88M+11837.2%
2023Dec 29, 2023$627.32K-99.5%
2022Dec 30, 2022$138.17M-8.7%
2021Dec 31, 2021$151.36M-58.7%
2020Dec 31, 2020$366.18M+0.4%
2019Dec 31, 2019$364.89M+178.1%
2018Dec 31, 2018$131.20M+75.3%
2017Dec 29, 2017$74.86M-8.0%
2016Dec 30, 2016$81.38M+21.0%
2015Dec 31, 2015$67.27M+9.2%
2014Dec 31, 2014$61.61M-76.8%
2013Dec 31, 2013$265.58M+125.9%
2012Dec 31, 2012$117.58M-19.8%
2011Dec 30, 2011$146.58M–

More Zivo Bioscience figures

See a number that looks wrong?